Literature DB >> 34424122

SARS-COV-2 seroprevalence among all healthcare workers in a tertiary hospital in Spain.

Mireia Cantero1, Rosario Millán-Pérez2, Elena Muñez3, Natalia Gómez-Lozano4, Jorge Anel-Pedroche2, Lina M Parra1, Maria L Rodríguez5, Angel Asensio1.   

Abstract

BACKGROUND: Healthcare workers (HCWs) have been a critical and vulnerable population during SARS-CoV-2 pandemic. The aim of this study was to determine the overall seroprevalence and to evaluate occupational risk factors among HCWs in one of the countries most affected by this pandemic.
METHODS: We conducted a seroprevalence study for SARS-CoV-2 in a tertiary hospital in Madrid (Spain) between 24 April and 8 May 2020. A total of 4894 HCWs were invited for serologic testing. Serum samples were tested for SARS-CoV-2 IgM and IgG antibodies using Enzyme Immunoassay (ELISA) and Electro-Chemiluminescence Immunoassay (ECLIA) techniques. We calculated odds ratios to assess association between demographic and occupational characteristics with SARS-CoV-2 seroconversion.
RESULTS: We processed 4324 serum samples. Overall, seroprevalence was of 16.6% (95% CI: 15.5-17.7). We found statistically significant differences in SARS-CoV-2 seroprevalence by type of employee, professional category, department and type of activity performed during the pandemic period, while no differences were identified between the personnel working in the COVID-19 wards compared to those working in non-COVID-19 wards. We confirmed 268 (26.7%) infections among 1005 hospital staff members tested by PCR. 60.5% of HCWs infected by SARS-CoV-2, assessed either by PCR or serology, could be considered asymptomatic or paucisymptomatic.
CONCLUSIONS: HCWs have an increased risk of SARS-CoV-2 infection but COVID-19 patient exposure was not a determining factor. Universal mask wearing should be mandatory in healthcare settings given the important number of asymptomatic and paucisymptomatic cases.

Entities:  

Keywords:  COVID-19; SARS-CoV-2; healthcare worker; infection prevention and control; risk factors; seroprevalence

Mesh:

Substances:

Year:  2021        PMID: 34424122     DOI: 10.1080/23744235.2021.1963468

Source DB:  PubMed          Journal:  Infect Dis (Lond)        ISSN: 2374-4243


  3 in total

1.  COVID-19 among workers of a comprehensive cancer centre between first and second epidemic waves (2020): a seroprevalence study in Catalonia, Spain.

Authors:  Paula Peremiquel-Trillas; Anna Saura-Lázaro; Yolanda Benavente-Moreno; Delphine Casabonne; Eva Loureiro; Sandra Cabrera; Angela Duran; Lidia Garrote; Immaculada Brao; Jordi Trelis; Maica Galán; Francesc Soler; Joaquim Julià; Dolça Cortasa; Maria Ángeles Domínguez; Adaia Albasanz-Puig; Carlota Gudiol; Dolors Ramírez-Tarruella; Joan Muniesa; Juan Pedro Rivas; Carles Muñoz-Montplet; Ana Sedano; Àngel Plans; Beatriz Calvo-Cerrada; Candela Calle; Ana Clopés; Dolors Carnicer-Pont; Laia Alemany; Esteve Fernández
Journal:  BMJ Open       Date:  2022-04-21       Impact factor: 3.006

2.  A Cohort Study of Seroprevalence of Antibodies Against SARS-CoV-2 Infection Among Healthcare Workers at a Tertiary Hospital in Saudi Arabia.

Authors:  Hayat Mushcab; Jaffar A Al-Tawfiq; Mohammed Ghamdi; Amani Babgi; Abdulrazack Amir; Salwa S Sheikh; Adel Darwisheh; Abrar Alobaid; Arulanantham Zechariah Jebakumar; Saeed Qahtani; Ahmed Al Sagheir
Journal:  Infect Drug Resist       Date:  2022-08-10       Impact factor: 4.177

3.  Application of a new protocol for providing obstetric care in an outpatient service during the COVID-19 pandemic in a public hospital in Madrid, Spain.

Authors:  Maria N Rayo; Irene Fernández-Buhigas; Emilia Ferrer; María Arrébola; María M Gil; Belén Santacruz
Journal:  Front Med (Lausanne)       Date:  2022-08-03
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.